Related Experiment Videos
Recurrent rectal cancer: diagnosis with dynamic MR imaging
M Müller-Schimpfle1, G Brix, G Layer
1Research Program Radiological Diagnostics and Therapy, German Cancer Research Center, Heidelberg.
Radiology
|December 1, 1993
Summary
Dynamic magnetic resonance (MR) imaging with pharmacokinetic mapping improves diagnostic accuracy for suspected rectal cancer recurrence. This technique enhances differentiation between benign and malignant pelvic lesions, aiding clinical decisions.
Area of Science:
- Radiology
- Oncology
- Medical Imaging
Background:
- Local recurrence of rectal carcinoma is a significant clinical challenge.
- Accurate differentiation between recurrent malignant and benign lesions is crucial for patient management.
Purpose of the Study:
- To assess the diagnostic utility of dynamic magnetic resonance (MR) imaging in detecting local recurrence of rectal cancer.
- To determine if dynamic MR imaging enhances diagnostic accuracy compared to conventional imaging.
Main Methods:
- Dynamic MR imaging was performed on 18 patients with 19 suspected lesions.
- T1-weighted (pre- and postcontrast) and T2-weighted spin-echo images were acquired.
- Pharmacokinetic mapping was computed and displayed to analyze tissue enhancement parameters.
Main Results:
- Conventional MR imaging showed variable sensitivity (91%-100%) and specificity (29%-43%).
- Pharmacokinetic mapping revealed significantly greater and faster enhancement in malignant lesions (n=12) compared to benign lesions (n=7).
- This quantitative analysis improved the differentiation of pelvic lesions.
Conclusions:
- Pharmacokinetic mapping of dynamic MR imaging provides in vivo physiological insights into pelvic tissues.
- This advanced MR technique aids in distinguishing benign from malignant lesions in rectal cancer recurrence.
- Dynamic MR imaging with pharmacokinetic mapping shows promise for improving diagnostic accuracy in this clinical setting.